DIN 02565676 — RETEVMO 80 MG
RETEVMO is a tablet of Selpercatinib marketed by ELI LILLY CANADA INC. The full Selpercatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02565676
- Brand name
- RETEVMO
- Active ingredient
- Selpercatinib
- Strength
- 80 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Selective RET kinase inhibitor (protein kinase inhibitor, antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Selpercatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02516918 | RETEVMO | 40 MG | CAPSULE | ELI LILLY CANADA INC | MARKETED |
| 02516926 | RETEVMO | 80 MG | CAPSULE | ELI LILLY CANADA INC | MARKETED |